NanoString Technologies, Inc.
MOLECULAR GENE SIGNATURES AND METHODS OF USING SAME

Last updated:

Abstract:

The invention provides methods of using expression levels of one or more cell gene signatures and/or combinations of cell gene signatures as selection criteria for selecting a patient having a cancer for treatment with a therapeutic. The invention further provides methods for selecting a patient having cancer who may benefit from a particular therapeutic, such as an immunotherapy and administering to the patient the immunotherapy to treat the cancer.

Status:
Application
Type:

Utility

Filling date:

20 May 2019

Issue date:

25 Nov 2021